Harnessing Patient Stem Cells and Machine Learning to Understand Neurological Disease and to Find Therapies
Description
Steven Finkbeiner will be sharing his work from 4-5pm on the Singleton Auditorium. There will be a social hour to follow from 5-6pm in the third floor atrium.
Speaker Bio
Dr. Finkbeiner’s group uses molecular and cellular tools to study the mechanisms of neuronal plasticity and neurodegeneration. Dr. Finkbeiner’s group has also done pioneering work in the field of automated cell imaging. Recent work has focused on understanding the etiology of several neurodegenerative diseases, including Huntington’s disease (HD), Amyotrophic Lateral Sclerosis (ALS), Parkinson’s disease (PD), Fronto-temporal dementia (FTD), and Alzheimer’s disease (AD). These studies have made use not only of rodent models of disease, but more recently neurons and glial derived from patient-derived induced pluripotent stem cells.